| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 822Q956KGM |
Structure
| InChI Key | HJXMNVQARNZTEE-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C12H14O2 |
| Molecular Weight | 190.24 |
| AlogP | 3.09 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 26.3 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 14.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 3 | |
|
Enzyme
Oxidoreductase
|
- | - | - | - | 11-11 | |
|
Membrane receptor
|
- | - | - | - | 1 |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Dementia, Vascular | 3 | D015140 | ClinicalTrials |
| Ischemic Stroke | 3 | D000083242 | ClinicalTrials |
| Cognitive Dysfunction | 2 | D060825 | ClinicalTrials |
| Stroke | 1 | D020521 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL248594 |
| DrugBank | DB12749 |
| DrugCentral | 5257 |
| EPA CompTox | DTXSID50863687 |
| FDA SRS | 822Q956KGM |
| Human Metabolome Database | HMDB0032064 |
| SureChEMBL | SCHEMBL716879 |
CONTENTS